Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about LILLY DRN
Recent news which mentions LILLY DRN
Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial
November 19, 2024
Tags
Healthy Returns
LILLY DRN
Health care industry
From
CNBC.com News
Cramer's Lightning Round: Eli Lilly is a buy
November 18, 2024
Tags
Investment Strategy
Business
Semtech Corp
From
CNBC.com News
Cramer says an RFK Jr.-run HHS ultimately won't tank junk food and drug industries
November 15, 2024
Tags
Business News
PepsiCo Inc/
U/S/ Markets
From
CNBC.com News
Amgen stock falls as analysts mull over weight loss drug’s bone density data
November 12, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Amgen Inc
From
CNBC.com News
‘Two-stocks’ are better than one? Repacking ‘pair trades'
November 09, 2024
Tags
Yum! Brands Inc
stocks
Stock markets
From
CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
November 08, 2024
Tags
Health care industry
Viking Therapeutics Inc
Healthy Returns
From
CNBC.com News
Jim Cramer says CEOs must properly explain the bad news in every quarter
October 30, 2024
Tags
Mad Money
Stock Picks
Investment strategy
From
CNBC.com News
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
October 30, 2024
Tags
Business
Pharmaceuticals
Breaking news
From
CNBC.com News
Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still fell short
October 30, 2024
Tags
Health care industry
Business
Pharmaceuticals
From
CNBC.com News
Jim Cramer's top 10 things to watch in the stock market Wednesday
October 30, 2024
Tags
Reddit Inc
Alphabet Inc
CNBC Investing Club: Cramer’s Morning Thoughts
From
CNBC.com News
Eli Lilly stock tumbles 10% after missing estimates and slashing profit guidance
October 30, 2024
Tags
Pharmaceuticals
Business
LILLY DRN
From
CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
October 29, 2024
Tags
Amgen Inc
Investment strategy
New York Times Co
From
CNBC.com News
Cramer’s week ahead: Earnings from Alphabet, Meta, Apple, Microsoft and Amazon
October 25, 2024
Tags
Bristol/Myers Squibb Co
Merck & Co Inc
Stock Picks
From
CNBC.com News
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
October 24, 2024
Tags
Science
Obesity
Weight management
From
CNBC.com News
Cramer's Lightning Round: 'Wait for a pullback' with Eli Lilly
October 23, 2024
Tags
Dutch Bros Inc
Markets
Stock Picks
From
CNBC.com News
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
October 23, 2024
Tags
Social issues
Amazon/com Inc
Biotech and Pharmaceuticals
From
CNBC.com News
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
October 23, 2024
Tags
Health & Science
Business News
Companies
From
CNBC.com News
KKM Financial's Essential 40 stock fund is now an ETF
October 21, 2024
Tags
Investment strategy
Amazon/com Inc
Investing
From
CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
October 15, 2024
Tags
LILLY DRN
Healthy Returns
Health care industry
From
CNBC.com News
Eli Lilly to trial use of weight loss drugs to combat unemployment in UK
October 15, 2024
Tags
Europe News
Biotech and Pharmaceuticals
Europe: Top News And Analysis
From
CNBC.com News
Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says
October 11, 2024
Tags
Europe: Top News And Analysis
Biotechnology
Novo Nordisk A/S
From
CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
October 03, 2024
Tags
NVIDIA Corp
Palantir Technologies Inc
Amazon/com Inc
From
CNBC.com News
5 things to know before the stock market opens Thursday
October 03, 2024
Tags
LILLY DRN
5 Things to Know
Business
From
CNBC.com News
Eli Lilly to build $4.5 billion research and manufacturing center to propel drug pipeline
October 02, 2024
Tags
LILLY DRN
Science
Health care industry
From
CNBC.com News
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.